Security
Kewaunee Scientific Corporation Common Stock · KEQU
KEQUNASDAQCommon stockCurrentCIK 55529Updated Nov 4, 2026
KEQU price & chart
Loading TradingView…
NASDAQ:KEQU on TradingView ↗About the company
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company’s portfolio includes laboratory casework, fume hoods, adaptable modular systems, healthcare storage solutions, epoxy resin work surfaces and sinks, biological safety cabinets, and other critical containment lab furniture solutions.
In the news
Recent filings
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
Regulation FD Disclosure
Items 7.01, 9.01
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 175,961,000Source | 189,148,000Source | 126,305,000Source | 189,075,000Source | 134,478,000Source | 175,800,000Source | 193,486,000Source | 132,018,000Source | 178,311,000Source | 194,654,000Source | 134,766,000Source | 118,898,000Source |
| Property, Plant and Equipment, NetUSD | 22,610,000Source | 23,849,000Source | 17,492,000Source | 23,155,000Source | 16,990,000Source | 21,932,000Source | 22,781,000Source | 17,112,000Source | 22,367,000Source | 23,174,000Source | 17,649,000Source | 16,402,000Source |
| GoodwillUSD | 12,487,000Source | 14,150,000Source | — | 12,487,000Source | — | 12,487,000Source | 12,487,000Source | — | 12,487,000Source | 12,487,000Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 16,679,000Source | 18,216,000Source | — | 17,063,000Source | — | 15,910,000Source | 17,447,000Source | — | 16,294,000Source | 17,831,000Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 8,153,000Source | 9,454,000Source | 21,312,000Source | 12,594,000Source | 25,963,000Source | 8,246,000Source | 19,489,000Source | 24,211,000Source | 9,950,000Source | 14,942,000Source | 23,267,000Source | 8,078,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 54,131,000Source | 57,419,000Source | 41,109,000Source | 59,017,000Source | 41,885,000Source | 58,197,000Source | 56,897,000Source | 43,545,000Source | 58,738,000Source | 62,384,000Source | 45,064,000Source | 46,081,000Source |
| Inventory, NetUSD | 32,907,000Source | 31,560,000Source | 21,845,000Source | 35,499,000Source | 18,659,000Source | 29,786,000Source | 34,923,000Source | 19,285,000Source | 30,533,000Source | 32,849,000Source | 20,679,000Source | 21,889,000Source |
| Assets, CurrentUSD | 103,578,000Source | 108,612,000Source | 96,156,000Source | 113,640,000Source | 96,436,000Source | 103,951,000Source | 117,148,000Source | 92,699,000Source | 105,397,000Source | 118,363,000Source | 96,817,000Source | 87,920,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 6,193,000Source | 7,298,000Source | 6,090,000Source | 5,445,000Source | 6,228,000Source | 5,707,000Source | 4,887,000Source | 4,683,000Source | 4,509,000Source | 5,966,000Source | 5,136,000Source | 6,135,000Source |
| Operating Lease, Right-of-Use AssetUSD | 10,449,000Source | 13,974,000Source | 7,827,000Source | 11,459,000Source | 6,941,000Source | 10,277,000Source | 12,022,000Source | 6,944,000Source | 10,791,000Source | 12,965,000Source | 7,454,000Source | 9,170,000Source |
| Other Assets, NoncurrentUSD | 6,588,000Source | 6,464,000Source | 4,830,000Source | 7,440,000Source | 5,806,000Source | 7,601,000Source | 7,390,000Source | 7,172,000Source | 7,146,000Source | 5,840,000Source | 5,445,000Source | 5,406,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 103,433,000Source | 127,027,000Source | 80,963,000Source | 117,358,000Source | 73,821,000Source | 98,580,000Source | 124,617,000Source | 74,505,000Source | 101,499,000Source | 128,409,000Source | 78,557,000Source | 80,413,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 7,423,000Source | 7,353,000Source | 7,270,000Source | 7,423,000Source | 7,353,000Source | 7,531,000Source | 7,421,000Source | 7,353,000Source | 7,423,000Source | 7,353,000Source | 7,273,000Source | 7,084,000Source |
| Retained Earnings (Accumulated Deficit)USD | 65,149,000Source | 54,069,000Source | 36,488,000Source | 64,457,000Source | 52,715,000Source | 70,243,000Source | 62,012,000Source | 49,707,000Source | 68,537,000Source | 58,919,000Source | 47,514,000Source | 28,761,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -4,767,000Source | -3,836,000Source | -3,877,000Source | -4,377,000Source | -3,574,000Source | -4,619,000Source | -4,213,000Source | -3,498,000Source | -4,614,000Source | -3,803,000Source | -3,382,000Source | -3,442,000Source |
| Stockholders' Equity Attributable to ParentUSD | 70,675,000Source | 60,801,000Source | 44,083,000Source | 69,852,000Source | 59,328,000Source | 75,005,000Source | 67,078,000Source | 56,023,000Source | 74,718,000Source | 64,457,000Source | 54,760,000Source | 37,409,000Source |
| Additional Paid in Capital, Common StockUSD | 6,517,000Source | 5,266,000Source | 5,046,000Source | 5,996,000Source | 4,885,000Source | 6,026,000Source | 5,505,000Source | 4,512,000Source | 7,019,000Source | 5,635,000Source | 5,406,000Source | 5,059,000Source |
| Liabilities and EquityUSD | 175,961,000Source | 189,148,000Source | 126,305,000Source | 189,075,000Source | 134,478,000Source | 175,800,000Source | 193,486,000Source | 132,018,000Source | 178,311,000Source | 194,654,000Source | 134,766,000Source | 118,898,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 48,785,000Source | 50,171,000Source | 42,142,000Source | 45,810,000Source | 36,471,000Source | 47,235,000Source | 50,486,000Source | 36,687,000Source | 48,351,000Source | 53,712,000Source | 40,780,000Source | 40,053,000Source |
| Operating Lease, Liability, CurrentUSD | 3,179,000Source | 3,395,000Source | 2,056,000Source | 3,381,000Source | 2,112,000Source | 4,100,000Source | 3,131,000Source | 2,031,000Source | 3,775,000Source | 3,275,000Source | 2,123,000Source | 1,967,000Source |
| Accounts Payable, CurrentUSD | 23,641,000Source | 24,530,000Source | 19,083,000Source | 22,660,000Source | 21,458,000Source | 21,557,000Source | 26,327,000Source | 20,619,000Source | 22,455,000Source | 27,033,000Source | 23,262,000Source | 23,599,000Source |
| Operating Lease, Liability, NoncurrentUSD | 6,496,000Source | 9,550,000Source | 5,741,000Source | 7,274,000Source | 5,035,000Source | 5,517,000Source | 8,014,000Source | 5,111,000Source | 6,287,000Source | 8,797,000Source | 5,434,000Source | 7,136,000Source |
| Deferred Income Tax Liabilities, NetUSD | 902,000Source | 1,093,000Source | 1,134,000Source | 1,217,000Source | 1,042,000Source | 995,000Source | 1,161,000Source | 1,273,000Source | 913,000Source | 1,098,000Source | 1,218,000Source | 943,000Source |
| Other Liabilities, NoncurrentUSD | 337,000Source | 447,000Source | 441,000Source | 349,000Source | 460,000Source | 291,000Source | 353,000Source | 462,000Source | 290,000Source | 364,000Source | 462,000Source | 455,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 1,853,000Source | 1,320,000Source | 1,259,000Source | 1,865,000Source | 1,329,000Source | 2,215,000Source | 1,791,000Source | 1,490,000Source | 2,094,000Source | 1,788,000Source | 1,449,000Source | 1,076,000Source |
| Additional Financial Items | ||||||||||||
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 3,462,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 943,000Source |
| Long-term Debt, Excluding Current Maturities | —Source | —Source | — | —Source | — | —Source | —Source | — | —Source | —Source | — | — |
| Long-term Debt, Current MaturitiesUSD | 5,000,000Source | 3,000,000Source | — | 3,000,000Source | — | 5,000,000Source | 3,000,000Source | — | 5,000,000Source | 3,000,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 16,333,000Source | 34,963,000Source | — | 32,250,000Source | — | 13,833,000Source | 34,380,000Source | — | 15,083,000Source | 34,685,000Source | — | — |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,076,000Source | 1,383,000Source | 2,538,000Source | 3,015,000Source | 1,843,000Source | 3,159,000Source | 10,465,000Source | 11,583,000Source | 19,057,000Source | 1,359,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 1,597,000Source | 1,563,000Source | 1,580,000Source | 806,000Source | 1,591,000Source | 1,549,000Source | 6,281,000Source | 4,759,000Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,899,000Source | 521,000Source | 2,126,000Source | 1,441,000Source | 1,028,000Source | 886,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -474,000Source | -5,468,000Source | -3,303,000Source | 6,738,000Source | -741,000Source | 4,947,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -747,000Source | 2,074,000Source | -2,316,000Source | -3,351,000Source | -1,210,000Source | -1,907,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -20,000Source | -2,203,000Source | -10,996,000Source | 515,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 1,976,000Source | 5,791,000Source | 18,633,000Source | 14,783,000Source | 19,564,000Source | -3,790,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 0Source | 28,735,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -772,000Source | -771,000Source | -3,937,000Source | -30,901,000Source | -4,373,000Source | -4,148,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 529,000Source | 0Source | 0Source | 1,596,000Source | 1,998,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -2,499,000Source | -1,463,000Source | -19,326,000Source | 7,411,000Source | -3,014,000Source | 14,931,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 88,000Source | 121,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,356,000Source | 3,277,000Source | -5,547,000Source | -8,774,000Source | 12,123,000Source | 6,921,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 10,347,000Source | 12,335,000Source | 13,679,000Source | 29,664,000Source | 10,261,000Source | 20,441,000Source | 11,617,000Source | 17,164,000Source | 25,938,000Source | 13,815,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 568,000Source | 524,000Source | 3,334,000Source | 3,374,000Source | 1,799,000Source | 1,862,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 3,560,000Source | 3,972,000Source | 6,240,000Source | 3,158,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -61,000Source | -280,000Source | -917,000Source | -67,000Source | -54,000Source | -72,000Source |
| Additional Financial Items | ||||||||||||
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | — | — | — | — | — | — | — | -4,019,000Source | — |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and CurtailmentUSD | — | — | — | — | — | — | — | — | — | — | — | -628,000Source |
| DepreciationUSD | — | — | — | — | — | — | 1,591,000Source | 1,549,000Source | 4,744,000Source | 3,990,000Source | 3,125,000Source | 2,867,000Source |
| GoodwillUSD | — | — | 12,487,000Source | 14,150,000Source | 12,487,000Source | — | 12,487,000Source | 12,487,000Source | 12,487,000Source | 12,487,000Source | — | — |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | — | 0Source | 0Source | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 528,000Source | -108,000Source | 915,000Source | 916,000Source | 717,000Source | 761,000Source | 3,268,000Source | 3,202,000Source | -5,938,000Source | 3,139,000Source |
| InterestExpenseNonoperatingUSD | — | — | 1,112,000Source | 1,137,000Source | 1,061,000Source | 442,000Source | 626,000Source | 1,058,000Source | 3,862,000Source | 3,214,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 692,000Source | 1,354,000Source | 2,445,000Source | 3,008,000Source | 1,706,000Source | 3,093,000Source | 9,618,000Source | 11,405,000Source | 18,753,000Source | 738,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 384,000Source | 29,000Source | 93,000Source | 7,000Source | 137,000Source | 66,000Source | 847,000Source | 178,000Source | 304,000Source | 621,000Source |
| Operating ExpensesUSD | — | — | 15,963,000Source | 16,129,000Source | 15,613,000Source | 9,518,000Source | 16,481,000Source | 16,120,000Source | 63,725,000Source | 51,098,000Source | 33,770,000Source | 30,224,000Source |
| Operating Lease, ExpenseUSD | — | — | 1,508,000Source | 1,306,000Source | 1,599,000Source | 878,000Source | 1,619,000Source | 1,458,000Source | 6,194,000Source | 4,433,000Source | 3,458,000Source | 3,344,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | 0Source | 1,497,000Source | — | — |
| Pension Cost (Reversal of Cost)USD | — | — | — | 0Source | — | 0Source | — | — | — | 0Source | 4,177,000Source | 71,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 202,000Source | 0Source |
| Amortization of Debt Issuance Costs | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 69,399,000Source | 67,167,000Source | 70,096,000Source | 47,764,000Source | 66,320,000Source | 71,104,000Source | 281,999,000Source | 240,472,000Source | 203,755,000Source | 219,494,000Source |
| Cost of RevenueUSD | — | — | 50,854,000Source | 48,788,000Source | 50,376,000Source | 33,812,000Source | 46,681,000Source | 50,174,000Source | 201,559,000Source | 171,615,000Source | 151,704,000Source | 183,906,000Source |
| Operating Income (Loss)USD | — | — | 2,582,000Source | 2,250,000Source | 4,107,000Source | 4,434,000Source | 3,158,000Source | 4,810,000Source | 16,715,000Source | 17,759,000Source | 18,281,000Source | 5,364,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 1,604,000Source | 1,275,000Source | 3,453,000Source | 3,931,000Source | 2,560,000Source | 3,920,000Source | 13,733,000Source | 14,785,000Source | 13,119,000Source | 4,498,000Source |
| Income Tax Expense (Benefit)USD | — | — | 528,000Source | -108,000Source | 915,000Source | 916,000Source | 717,000Source | 761,000Source | 3,268,000Source | 3,202,000Source | -5,938,000Source | 3,139,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 384,000Source | 29,000Source | 93,000Source | 7,000Source | 137,000Source | 66,000Source | 847,000Source | 178,000Source | 304,000Source | 621,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 692,000Source | 1,354,000Source | 2,445,000Source | 3,008,000Source | 1,706,000Source | 3,093,000Source | 9,618,000Source | 11,405,000Source | 18,753,000Source | 738,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.24Source | 0.47Source | 0.85Source | 1.05Source | 0.59Source | 1.08Source | 3.36Source | 3.98Source | 6.51Source | 0.26Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.23Source | 0.45Source | 0.82Source | 1.01Source | 0.58Source | 1.04Source | 3.22Source | 3.83Source | 6.38Source | 0.25Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 2,866,000Source | 2,872,000Source | 2,866,000Source | 2,872,000Source | 2,880,000Source | 2,851,000Source | 2,863,000Source | 2,862,000Source | 2,879,000Source | 2,824,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 2,983,000Source | 2,995,000Source | 2,990,000Source | 2,974,000Source | 2,921,000Source | 2,963,000Source | 2,983,000Source | 2,979,000Source | 2,938,000Source | 2,902,000Source |
| Interest Expense (non-operating)USD | — | — | 1,112,000Source | 1,137,000Source | 1,061,000Source | 442,000Source | 626,000Source | 1,058,000Source | 3,862,000Source | 3,214,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 3,288,000Source | 5,405,000Source | 5,058,000Source | 2,624,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | — | — | — | — | — | — | — | -4,019,000Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | — | 0Source | 0Source | — | — |
| Gross ProfitUSD | — | — | 18,545,000Source | 18,379,000Source | 19,720,000Source | 13,952,000Source | 19,639,000Source | 20,930,000Source | 80,440,000Source | 68,857,000Source | 52,051,000Source | 35,588,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 6,812,000Source | — | — | — |
| Interest ExpenseUSD | — | — | — | 1,137,000Source | — | 442,000Source | — | 1,058,000Source | — | — | 1,799,000Source | 1,734,000Source |
| Operating ExpensesUSD | — | — | 15,963,000Source | 16,129,000Source | 15,613,000Source | 9,518,000Source | 16,481,000Source | 16,120,000Source | 63,725,000Source | 51,098,000Source | 33,770,000Source | 30,224,000Source |
| Operating Lease, ExpenseUSD | — | — | 1,508,000Source | 1,306,000Source | 1,599,000Source | 878,000Source | 1,619,000Source | 1,458,000Source | 6,194,000Source | 4,433,000Source | 3,458,000Source | 3,344,000Source |
| Other IncomeUSD | — | — | 134,000Source | 162,000Source | 407,000Source | -61,000Source | 28,000Source | 168,000Source | 880,000Source | 240,000Source | 814,000Source | 939,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | 898,000Source | 919,000Source | 920,000Source | 1,012,000Source |
| Interest Expense, Debt | — | — | — | — | — | — | — | —Source | — | — | — | — |
Filing attachments
d349762dex991.htm · 8-K · 2026-11-02
Exhibit 99.1 Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc. Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III ──────────────────────────────────────────────────────────────────── 704/871-3274 STATESVILLE, N.C. November 2, 2026 - PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that it has entered into a definitive agreement to acquire Nycom, Inc. (“Nycom”), the largest lab dealer in the U…
Read attachment ↗d349762dex992.htm · 8-K · 2026-11-02
Exhibit 99.2 A Letter to Our Shareholders Dear Shareholders, It is inspiring to consider that Kewaunee is entering its thirteenth decade as a leading manufacturer of furniture, casework, and technical products that have been used in many of the most remarkable scientific discoveries in history. That core business has served us and the scientific community well over these many years. But as the world of discovery and the markets we serve evolve, so too must our business to take advantage of the …
Read attachment ↗d55511dex991.htm · 8-K · 2025-08-27
EX-99.1 2 d55511dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 KEWAUNEE SCIENTIFIC CORPORATION NASDAQ: KEQU Special Note Regarding Forward-Looking Statements Certain statements in this document constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the Reform Act ). All statements other than statements of historical fact included in this Annual Report, including statements regarding the Company's future financial condition, results of ope…
Read attachment ↗d55511dex992.htm · 8-K · 2025-08-27
EX-99.2 3 d55511dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 ANNUAL SHAREHOLDER SPEECH AUG 27, 2025 Kewaunee Scientific Corporation Annual Shareholder Speech August 27, 2025 Good morning. I would like to extend a warm welcome to our shareholders who have set aside time to join us today at Kewaunee’s 2025 annual shareholder meeting. This year’s meeting is again being conducted virtually, providing our shareholders with a more accessible format in which to participate. Before proceeding, a b…
Read attachment ↗